The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157 FDA approval status 2026: Is it legal? Veedma